tiprankstipranks
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Japanese Market

Sumitomo Dainippon Pharma Co (4506) Stock Forecast & Price Target

7 Followers
See the Price Targets and Ratings of:

4506 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Sumitomo
Dainippon Pharma Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4506 Stock 12 Month Forecast

There Are No Analyst Ratings for JP:4506 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

4506 Financial Forecast

4506 Earnings Forecast

Next quarter’s earnings estimate for 4506 is -¥15.24 with a range of -¥15.24 to -¥15.24. The previous quarter’s EPS was ¥22.19. 4506 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 4506 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4506 is -¥15.24 with a range of -¥15.24 to -¥15.24. The previous quarter’s EPS was ¥22.19. 4506 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 4506 has Performed in-line its overall industry.

4506 Sales Forecast

Next quarter’s sales forecast for 4506 is ¥99.53B with a range of ¥87.15B to ¥111.91B. The previous quarter’s sales results were ¥120.62B. 4506 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 4506 has Performed in-line its overall industry.
Next quarter’s sales forecast for 4506 is ¥99.53B with a range of ¥87.15B to ¥111.91B. The previous quarter’s sales results were ¥120.62B. 4506 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 4506 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
¥2,700
Buy
45.59%
Upside
Reiterated
12/15/25
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
J.P. Morgan Analyst forecast on JP:4506
J.P. Morgan
J.P. Morgan
¥1,600¥1,880
Buy
1.38%
Upside
Reiterated
09/05/25
J.P. Morgan Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Citi
¥1,000¥1,260
Sell
-32.06%
Downside
Reiterated
08/22/25
Citi Sticks to Its Sell Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Morgan Stanley Analyst forecast on JP:4506
Morgan Stanley
Morgan Stanley
¥550¥1,350
Hold
-27.20%
Downside
Upgraded
08/22/25
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan StanleySumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
¥2,700
Buy
45.59%
Upside
Reiterated
12/15/25
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
J.P. Morgan Analyst forecast on JP:4506
J.P. Morgan
J.P. Morgan
¥1,600¥1,880
Buy
1.38%
Upside
Reiterated
09/05/25
J.P. Morgan Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Citi
¥1,000¥1,260
Sell
-32.06%
Downside
Reiterated
08/22/25
Citi Sticks to Its Sell Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Morgan Stanley Analyst forecast on JP:4506
Morgan Stanley
Morgan Stanley
¥550¥1,350
Hold
-27.20%
Downside
Upgraded
08/22/25
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan StanleySumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sumitomo Dainippon Pharma Co

3 Months
xxx
Success Rate
6/7 ratings generated profit
86%
Average Return
+45.81%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +45.81% per trade.
1 Year
Success Rate
6/7 ratings generated profit
86%
Average Return
+109.83%
Copying Stephen Barker's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +109.83% per trade.
2 Years
xxx
Success Rate
6/7 ratings generated profit
86%
Average Return
+113.96%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +113.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4506 Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
0
0
In the current month, 4506 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4506 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

4506 Stock Forecast FAQ

What is JP:4506’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:4506’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:4506, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sumitomo Dainippon Pharma Co Ltd a Buy, Sell or Hold?
      Currently, no data Available
      What is Sumitomo Dainippon Pharma Co Ltd’s share price target?
      Currently, no data Available
      What do analysts say about Sumitomo Dainippon Pharma Co Ltd?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sumitomo Dainippon Pharma Co Ltd?
      To buy shares of JP:4506, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.